 | • レポートコード：MRC2312MG07054 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のC型肝炎治療薬市場規模と予測を収録しています。・世界のC型肝炎治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界のC型肝炎治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のC型肝炎治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「阻害剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 C型肝炎治療薬のグローバル主要企業は、AbbVie, Inc.、 Bristol-Myers Squibb Company、 F. Hoffmann-La Roche AG、 Gilead Sciences, Inc.、 GlaxoSmithKline PLC、 Johnson & Johnson、 Kadmon Holdings, Inc.、 Merck & Co., Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、C型肝炎治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のC型肝炎治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のC型肝炎治療薬市場：タイプ別市場シェア、2022年 ・阻害剤、インターフェロン 世界のC型肝炎治療薬市場：用途別、2018年-2023年、2024年-2029年 世界のC型肝炎治療薬市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界のC型肝炎治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のC型肝炎治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるC型肝炎治療薬のグローバル売上、2018年-2023年 ・主要企業におけるC型肝炎治療薬のグローバル売上シェア、2022年 ・主要企業におけるC型肝炎治療薬のグローバル販売量、2018年-2023年 ・主要企業におけるC型肝炎治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AbbVie, Inc.、 Bristol-Myers Squibb Company、 F. Hoffmann-La Roche AG、 Gilead Sciences, Inc.、 GlaxoSmithKline PLC、 Johnson & Johnson、 Kadmon Holdings, Inc.、 Merck & Co., Inc. ************************************************************* ・調査・分析レポートの概要 C型肝炎治療薬市場の定義 市場セグメント 世界のC型肝炎治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のC型肝炎治療薬市場規模 世界のC型肝炎治療薬市場規模：2022年 VS 2029年 世界のC型肝炎治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのC型肝炎治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のC型肝炎治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：阻害剤、インターフェロン C型肝炎治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 C型肝炎治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別C型肝炎治療薬市場規模 2022年と2029年 地域別C型肝炎治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AbbVie, Inc.、 Bristol-Myers Squibb Company、 F. Hoffmann-La Roche AG、 Gilead Sciences, Inc.、 GlaxoSmithKline PLC、 Johnson & Johnson、 Kadmon Holdings, Inc.、 Merck & Co., Inc. ... |
This research report provides a comprehensive analysis of the Hepatitis C Treatment Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hepatitis C Treatment Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hepatitis C Treatment Drug, challenges faced by the industry, and potential opportunities for market players.
The global Hepatitis C Treatment Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hepatitis C Treatment Drug market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hepatitis C Treatment Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Hepatitis C Treatment Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hepatitis C treatment drugs need to be adjusted individually according to the patient’s genotype, condition, liver function and other factors to formulate the most appropriate treatment plan.
Key Features:
The research report on the Hepatitis C Treatment Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hepatitis C Treatment Drug market.
Market Overview: The report provides a comprehensive overview of the Hepatitis C Treatment Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Inhibitors, Interferons), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hepatitis C Treatment Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hepatitis C Treatment Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hepatitis C Treatment Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Hepatitis C Treatment Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Hepatitis C Treatment Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hepatitis C Treatment Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hepatitis C Treatment Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hepatitis C Treatment Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Hepatitis C Treatment Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Inhibitors
Interferons
Market segment by Application
Hospital
Clinic
Others
Global Hepatitis C Treatment Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AbbVie, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Kadmon Holdings, Inc.
Merck & Co., Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis C Treatment Drug, market overview.
Chapter 2: Global Hepatitis C Treatment Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis C Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis C Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis C Treatment Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hepatitis C Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis C Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis C Treatment Drug Overall Market Size
2.1 Global Hepatitis C Treatment Drug Market Size: 2022 VS 2029
2.2 Global Hepatitis C Treatment Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatitis C Treatment Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatitis C Treatment Drug Players in Global Market
3.2 Top Global Hepatitis C Treatment Drug Companies Ranked by Revenue
3.3 Global Hepatitis C Treatment Drug Revenue by Companies
3.4 Global Hepatitis C Treatment Drug Sales by Companies
3.5 Global Hepatitis C Treatment Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis C Treatment Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis C Treatment Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis C Treatment Drug Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis C Treatment Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis C Treatment Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hepatitis C Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Inhibitors
4.1.3 Interferons
4.2 By Type – Global Hepatitis C Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Hepatitis C Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Hepatitis C Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Hepatitis C Treatment Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Hepatitis C Treatment Drug Sales & Forecasts
4.3.1 By Type – Global Hepatitis C Treatment Drug Sales, 2018-2023
4.3.2 By Type – Global Hepatitis C Treatment Drug Sales, 2024-2029
4.3.3 By Type – Global Hepatitis C Treatment Drug Sales Market Share, 2018-2029
4.4 By Type – Global Hepatitis C Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hepatitis C Treatment Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Hepatitis C Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Hepatitis C Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Hepatitis C Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Hepatitis C Treatment Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Hepatitis C Treatment Drug Sales & Forecasts
5.3.1 By Application – Global Hepatitis C Treatment Drug Sales, 2018-2023
5.3.2 By Application – Global Hepatitis C Treatment Drug Sales, 2024-2029
5.3.3 By Application – Global Hepatitis C Treatment Drug Sales Market Share, 2018-2029
5.4 By Application – Global Hepatitis C Treatment Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hepatitis C Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Hepatitis C Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Hepatitis C Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Hepatitis C Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Hepatitis C Treatment Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Hepatitis C Treatment Drug Sales & Forecasts
6.3.1 By Region – Global Hepatitis C Treatment Drug Sales, 2018-2023
6.3.2 By Region – Global Hepatitis C Treatment Drug Sales, 2024-2029
6.3.3 By Region – Global Hepatitis C Treatment Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hepatitis C Treatment Drug Revenue, 2018-2029
6.4.2 By Country – North America Hepatitis C Treatment Drug Sales, 2018-2029
6.4.3 US Hepatitis C Treatment Drug Market Size, 2018-2029
6.4.4 Canada Hepatitis C Treatment Drug Market Size, 2018-2029
6.4.5 Mexico Hepatitis C Treatment Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hepatitis C Treatment Drug Revenue, 2018-2029
6.5.2 By Country – Europe Hepatitis C Treatment Drug Sales, 2018-2029
6.5.3 Germany Hepatitis C Treatment Drug Market Size, 2018-2029
6.5.4 France Hepatitis C Treatment Drug Market Size, 2018-2029
6.5.5 U.K. Hepatitis C Treatment Drug Market Size, 2018-2029
6.5.6 Italy Hepatitis C Treatment Drug Market Size, 2018-2029
6.5.7 Russia Hepatitis C Treatment Drug Market Size, 2018-2029
6.5.8 Nordic Countries Hepatitis C Treatment Drug Market Size, 2018-2029
6.5.9 Benelux Hepatitis C Treatment Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hepatitis C Treatment Drug Revenue, 2018-2029
6.6.2 By Region – Asia Hepatitis C Treatment Drug Sales, 2018-2029
6.6.3 China Hepatitis C Treatment Drug Market Size, 2018-2029
6.6.4 Japan Hepatitis C Treatment Drug Market Size, 2018-2029
6.6.5 South Korea Hepatitis C Treatment Drug Market Size, 2018-2029
6.6.6 Southeast Asia Hepatitis C Treatment Drug Market Size, 2018-2029
6.6.7 India Hepatitis C Treatment Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hepatitis C Treatment Drug Revenue, 2018-2029
6.7.2 By Country – South America Hepatitis C Treatment Drug Sales, 2018-2029
6.7.3 Brazil Hepatitis C Treatment Drug Market Size, 2018-2029
6.7.4 Argentina Hepatitis C Treatment Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hepatitis C Treatment Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hepatitis C Treatment Drug Sales, 2018-2029
6.8.3 Turkey Hepatitis C Treatment Drug Market Size, 2018-2029
6.8.4 Israel Hepatitis C Treatment Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatitis C Treatment Drug Market Size, 2018-2029
6.8.6 UAE Hepatitis C Treatment Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie, Inc.
7.1.1 AbbVie, Inc. Company Summary
7.1.2 AbbVie, Inc. Business Overview
7.1.3 AbbVie, Inc. Hepatitis C Treatment Drug Major Product Offerings
7.1.4 AbbVie, Inc. Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie, Inc. Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Hepatitis C Treatment Drug Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 F. Hoffmann-La Roche AG
7.3.1 F. Hoffmann-La Roche AG Company Summary
7.3.2 F. Hoffmann-La Roche AG Business Overview
7.3.3 F. Hoffmann-La Roche AG Hepatitis C Treatment Drug Major Product Offerings
7.3.4 F. Hoffmann-La Roche AG Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.3.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.4 Gilead Sciences, Inc.
7.4.1 Gilead Sciences, Inc. Company Summary
7.4.2 Gilead Sciences, Inc. Business Overview
7.4.3 Gilead Sciences, Inc. Hepatitis C Treatment Drug Major Product Offerings
7.4.4 Gilead Sciences, Inc. Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.4.5 Gilead Sciences, Inc. Key News & Latest Developments
7.5 GlaxoSmithKline PLC
7.5.1 GlaxoSmithKline PLC Company Summary
7.5.2 GlaxoSmithKline PLC Business Overview
7.5.3 GlaxoSmithKline PLC Hepatitis C Treatment Drug Major Product Offerings
7.5.4 GlaxoSmithKline PLC Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline PLC Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Hepatitis C Treatment Drug Major Product Offerings
7.6.4 Johnson & Johnson Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Kadmon Holdings, Inc.
7.7.1 Kadmon Holdings, Inc. Company Summary
7.7.2 Kadmon Holdings, Inc. Business Overview
7.7.3 Kadmon Holdings, Inc. Hepatitis C Treatment Drug Major Product Offerings
7.7.4 Kadmon Holdings, Inc. Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.7.5 Kadmon Holdings, Inc. Key News & Latest Developments
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Company Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Hepatitis C Treatment Drug Major Product Offerings
7.8.4 Merck & Co., Inc. Hepatitis C Treatment Drug Sales and Revenue in Global (2018-2023)
7.8.5 Merck & Co., Inc. Key News & Latest Developments
8 Global Hepatitis C Treatment Drug Production Capacity, Analysis
8.1 Global Hepatitis C Treatment Drug Production Capacity, 2018-2029
8.2 Hepatitis C Treatment Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis C Treatment Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis C Treatment Drug Supply Chain Analysis
10.1 Hepatitis C Treatment Drug Industry Value Chain
10.2 Hepatitis C Treatment Drug Upstream Market
10.3 Hepatitis C Treatment Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis C Treatment Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
